Kusaka N - Search Results

1

Anterior urethral recurrence of superficial bladder cancer: its clinical significance.

Saika T, Tsushima T, Nasu Y, Arata R, Kaku H, Akebi N, Kusaka N, Kumon H. Saika T, et al. Among authors: kusaka n. Acta Med Okayama. 2003 Dec;57(6):293-7. doi: 10.18926/AMO/32815. Acta Med Okayama. 2003. PMID: 14726966 Free article.

2

Clinical study of G3 superficial bladder cancer without concomitant CIS treated with conservative therapy.

Saika T, Tsushima T, Nasu Y, Arata R, Kaku H, Kusaka N, Kumon H. Saika T, et al. Among authors: kusaka n. Jpn J Clin Oncol. 2002 Nov;32(11):461-5. doi: 10.1093/jjco/hyf103. Jpn J Clin Oncol. 2002. PMID: 12499418

3

Effects of gonadotropin-releasing hormone agonists on bone metabolism markers and bone mineral density in patients with prostate cancer.

Miyaji Y, Saika T, Yamamoto Y, Kusaka N, Arata R, Ebara S, Nasu Y, Tsushima T, Kumon H. Miyaji Y, et al. Among authors: kusaka n. Urology. 2004 Jul;64(1):128-31. doi: 10.1016/j.urology.2004.03.012. Urology. 2004. PMID: 15245949

4

Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy.

Nasu Y, Saika T, Ebara S, Kusaka N, Kaku H, Abarzua F, Manabe D, Thompson TC, Kumon H. Nasu Y, et al. Among authors: kusaka n. Mol Ther. 2007 Apr;15(4):834-40. doi: 10.1038/sj.mt.6300096. Epub 2007 Feb 27. Mol Ther. 2007. PMID: 17327829 Free article. Clinical Trial.

5

Treatment of androgen-independent prostate cancer with dexamethasone: a prospective study in stage D2 patients.

Saika T, Kusaka N, Tsushima T, Yamato T, Ohashi T, Suyama B, Arata R, Nasu Y, Kumon H; Okayama Urological Cancer Collaborating Group. Saika T, et al. Among authors: kusaka n. Int J Urol. 2001 Jun;8(6):290-4. doi: 10.1046/j.1442-2042.2001.00302.x. Int J Urol. 2001. PMID: 11389744 Free article. Clinical Trial.

6

Suicide gene therapy for urogenital cancer: current outcome and prospects.

Nasu Y, Kusaka N, Saika T, Tsushima T, Kumon H. Nasu Y, et al. Among authors: kusaka n. Mol Urol. 2000 Summer;4(2):67-71. doi: 10.1089/10915360050138611. Mol Urol. 2000. PMID: 12006245 Review.

7

Prostate specific antigen complexed to alpha-1-antichymotrypsin in patients with intermediate prostate specific antigen levels.

Saika T, Tsushima T, Nasu Y, Kusaka N, Miyaji Y, Takamoto H, Takeda K, Uno S, Kumon H; Okayama Urological Cancer Collaborating Group. Saika T, et al. Among authors: kusaka n. Cancer. 2002 Mar 15;94(6):1685-91. doi: 10.1002/cncr.10377. Cancer. 2002. PMID: 11920529 Free article. Clinical Trial.

8

Transrectal ultrasound for monitoring murine orthotopic prostate tumor.

Kusaka N, Nasu Y, Arata R, Saika T, Tsushima T, Kraaij R, Bangma CH, Kumon H. Kusaka N, et al. Prostate. 2001 May 1;47(2):118-24. doi: 10.1002/pros.1054. Prostate. 2001. PMID: 11340634

9

Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model.

Saika T, Kusaka N, Mouraviev V, Satoh T, Kumon H, Timme TL, Thompson TC. Saika T, et al. Among authors: kusaka n. Cancer Gene Ther. 2006 Jan 1;13(1):91-8. doi: 10.1038/sj.cgt.7700872. Cancer Gene Ther. 2006. PMID: 16052232

10

Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer.

Satoh T, Timme TL, Saika T, Ebara S, Yang G, Wang J, Ren C, Kusaka N, Mouraviev V, Thompson TC. Satoh T, et al. Among authors: kusaka n. Hum Gene Ther. 2003 Jan 20;14(2):91-101. doi: 10.1089/104303403321070793. Hum Gene Ther. 2003. PMID: 12614561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters